International Journal of Cancer, Heidelberg, Germany.
Leibniz-Institute DSMZ - Deutsche Sammlung von Mikroorganismen und Zellkulturen, Braunschweig, Germany.
EMBO J. 2022 Jul 18;41(14):e111307. doi: 10.15252/embj.2022111307. Epub 2022 Jun 27.
Immortalized or continuous cell lines are invaluable tools in basic and preclinical research. However, the widespread use of misidentified cell lines is a serious threat to scientific reproducibility. Based on the experiences of mandatory cell line authentication at the International Journal of Cancer (IJC), we provide an overview of the issues pertinent to misidentified cell lines and discuss available solutions. We also summarize the lessons learned, revealing that at least 5% of the human cell lines used in manuscripts considered for peer review are misidentified. About 4% of the considered manuscripts are rejected for severe cell line problems, and most are subsequently published in other journals. In order to diminish such malpractice and its consequences for the scientific record, we postulate that strict multi-layered quality control is essential. Besides journals and publishers, we encourage scientists, research institutions, and funders to take action on the matter and revise their respective policies. Hence, we provide concrete recommendations on introducing regular authentication schemes and staff training, and discuss future steps for enhancing good cell culture practices.
永生化或连续细胞系是基础和临床前研究中非常有价值的工具。然而,误用细胞系的广泛使用对科学可重复性构成了严重威胁。基于国际癌症杂志(IJC)强制进行细胞系认证的经验,我们概述了与误识别细胞系相关的问题,并讨论了可用的解决方案。我们还总结了经验教训,揭示了在提交同行评审的论文中,至少有 5%的人使用的细胞系被误识别。大约 4%的考虑中的论文因严重的细胞系问题而被拒绝,并且大多数随后在其他期刊上发表。为了减少这种不当行为及其对科学记录的影响,我们假设严格的多层次质量控制至关重要。除了期刊和出版商,我们还鼓励科学家、研究机构和资助者对此事采取行动并修改各自的政策。因此,我们提供了关于引入定期认证计划和员工培训的具体建议,并讨论了加强良好细胞培养实践的未来步骤。